Advertisement

European Journal of Nutrition

, Volume 52, Issue 6, pp 1641–1648 | Cite as

Serum leptin and total dietary energy intake: the INTERLIPID Study

  • Yasuyuki NakamuraEmail author
  • Hirotsugu Ueshima
  • Nagako Okuda
  • Yoshitaka Murakami
  • Katsuyuki Miura
  • Yoshikuni Kita
  • Tomonori Okamura
  • Akira Okayama
  • Tanvir C. Turin
  • Sohel R. Choudhry
  • Beatriz Rodriguez
  • J. David Curb
  • Jeremiah Stamler
Original Contribution

Abstract

Purpose

It has been hypothesized that leptin-induced appetite suppression is impaired in obese individuals, but little human evidence is available documenting this. We investigated relations between serum leptin and total energy intake using INTERLIPID/INTERMAP data on Japanese–Americans in Hawaii and Japanese in Japan.

Methods

Serum leptin and nutrient intakes were examined by standardized methods in men and women aged 40–59 years from two population samples, one Japanese–American in Hawaii (88 men, 94 women), the other Japanese in central Japan (123 men, 111 women). Multiple linear regression analyses stratified by BMI category (<25 kg/m2, 25–29.9 kg/m2, and ≥30 kg/m2) with adjustment for possible confounders were used to examine the relation between log-leptin and total dietary energy intake.

Results

In multivariate regression analyses, in those with BMI < 25 kg/m2 and in those with BMI between 25 and 29.9 kg/m2, log-leptin was not significantly related to total dietary energy intake; in those with BMI ≥ 30 kg/m2, it was significantly inversely related to total dietary energy intake (P = 0.029), independent of body weight and physical activity. Physical activity score was significantly positively related to total dietary energy intake only in participants with BMI < 25 kg/m2 (P < 0.001).

Conclusion

Leptin was significantly inversely associated with dietary energy intake in obese persons, but not in overweight and normal-weight persons.

Keywords

Leptin Japanese in Japan and Hawaii Obesity Body mass Total energy intake Population study 

Notes

Acknowledgments

The INTERMAP/INTERLIPID Study has been accomplished through the fine work of staff at local, national, and international centers. A partial listing of colleagues is in the acknowledgement of reference 10. This study was supported in part by a grant-in-aid of the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research: (A) 090357003, (C) 17590563, and (C) 19590655 in Japan and the Suntory Company; the Pacific Research Institute is supported by the Robert Perry Fund and the Hawaii Community Foundation. The INTERMAP Hawaii Center was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (Grant 5-RO1-HL54868-03). The INTERMAP Study is supported by the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, U.S.A. (Grant 2-RO1-HL50490), as well as national and local agencies in the four countries.

Conflict of interest

All authors have no conflict of interest.

References

  1. 1.
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1984) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432CrossRefGoogle Scholar
  2. 2.
    Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI (1997) Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270–278CrossRefGoogle Scholar
  3. 3.
    Rosenbaum M, Leibel RL (1999) The role of leptin in human physiology. N Engl J Med 341:913–915CrossRefGoogle Scholar
  4. 4.
    Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295CrossRefGoogle Scholar
  5. 5.
    Caro JF, Kolaczynski JW, Nyce MR et al (1996) Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348(9021):159–161CrossRefGoogle Scholar
  6. 6.
    Correia ML, Rahmouni K (2006) Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes Metab 8:603–610CrossRefGoogle Scholar
  7. 7.
    Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL (2002) The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51:439–442CrossRefGoogle Scholar
  8. 8.
    Myers MG Jr, Heymsfield SB, Haft C et al (2012) Challenges and opportunities of defining clinical leptin resistance. Cell Metab 15:150–156CrossRefGoogle Scholar
  9. 9.
    Ueshima H, Okayama A, Saitoh S et al (2003) Differences in cardiovascular disease risk factors between Japanese in Japan and Japanese–Americans in Hawaii: the INTERLIPID study. J Hum Hypertens 17:631–639CrossRefGoogle Scholar
  10. 10.
    Okuda N, Ueshima H, Okayama A et al (2005) Relation of long chain n−3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese–American men in Hawaii: the INTERLIPID study. Atherosclerosis 178:371–379CrossRefGoogle Scholar
  11. 11.
    Stamler J, Elliott P, Dennis B et al (2003) INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens 17:591–608CrossRefGoogle Scholar
  12. 12.
    Dennis B, Stamler J, Buzzard M et al (2003) INTERMAP: the dietary data—process and quality control. J Hum Hypertens 17:609–622CrossRefGoogle Scholar
  13. 13.
    Nakamura Y, Ueshima H, Okuda N et al (2008) Relation of dietary and other lifestyle traits to difference in serum adiponectin concentration of Japanese in Japan and Hawaii: the INTERLIPID Study. Am J Clin Nutr 88:424–430Google Scholar
  14. 14.
    Kannel WB, Sorlie P (1979) Some health benefits of physical activity. The Framingham Study. Arch Intern Med 139:857–861CrossRefGoogle Scholar
  15. 15.
    Korbonits M, Trainer PJ, Little JA et al (1997) Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin Endocrinol (Oxf) 46:751–757CrossRefGoogle Scholar
  16. 16.
    Poretsky L, Lesser M, Brillon D (2001) Lack of postprandial leptin peaks in patients with type 2 diabetes mellitus. Diabetes Obes Metab 3:105–111CrossRefGoogle Scholar
  17. 17.
    Broeder CE, Burrhus KA, Svanevik LS, Wilmore JH (1992) The effects of aerobic fitness on resting metabolic rate. Am J Clin Nutr 55:795–801Google Scholar
  18. 18.
    Licinio J, Mantzoros C, Negrão AB et al (1997) Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 3:575–579CrossRefGoogle Scholar
  19. 19.
    Schoeller DA, Cella LK, Sinha MK, Caro JF (1997) Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 100:1882–1887CrossRefGoogle Scholar
  20. 20.
    Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P (1995) Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269(5223):546–549CrossRefGoogle Scholar
  21. 21.
    Halaas JL, Gajiwala KS, Maffei M et al (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269(5223):543–546CrossRefGoogle Scholar
  22. 22.
    Pelleymounter MA, Cullen MJ, Baker MB et al (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269(5223):540–543CrossRefGoogle Scholar
  23. 23.
    Farooqi IS, Jebb SA, Langmack G et al (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879–884CrossRefGoogle Scholar
  24. 24.
    Heymsfield SB, Greenberg AS, Fujioka K et al (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568–1575CrossRefGoogle Scholar
  25. 25.
    Westerterp-Plantenga MS, Saris WH, Hukshorn CJ, Campfield LA (2001) Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr 74:426–434Google Scholar
  26. 26.
    Kissileff HR, Thornton JC, Torres MI et al (2012) Leptin reverses declines in satiation in weight-reduced obese humans. Am J Clin Nutr 95:309–317CrossRefGoogle Scholar
  27. 27.
    Larsson H, Elmståhl S, Berglund G, Ahrén B (1998) Evidence for leptin regulation of food intake in humans. J Clin Endocrinol Metab 83:4382–4385CrossRefGoogle Scholar
  28. 28.
    Murakami K, Sasaki S, Takahashi Y et al (2007) Nutrient and food intake in relation to serum leptin concentration among young Japanese women. Nutrition 23:461–468CrossRefGoogle Scholar
  29. 29.
    Chu NF, Spiegelman D, Yu J, Rifai N, Hotamisligil GS, Rimm EB (2001) Plasma leptin concentrations and four-year weight gain among US men. Int J Obes Relat Metab Disord 25:346–353CrossRefGoogle Scholar
  30. 30.
    Shek EW, Brands MW, Hall JE (1998) Chronic leptin infusion increases arterial pressure. Hypertension 31:409–414CrossRefGoogle Scholar
  31. 31.
    Nakamura Y, Ueshima H, Okuda N et al (2009) Relation of serum leptin to blood pressure of Japanese in Japan and Japanese–Americans in Hawaii. Hypertension 54:1416–1422CrossRefGoogle Scholar
  32. 32.
    Nicklas BJ, Katzel LI, Ryan AS, Dennis KE, Goldberg AP (1997) Gender differences in the response of plasma leptin concentrations to weight loss in obese older individuals. Obes Res 5:62–68CrossRefGoogle Scholar
  33. 33.
    Niskanen LK, Haffner S, Karhunen LJ, Turpeinen AK, Miettinen H, Uusitupa MI (1997) Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. Eur J Endocrinol 137(61–6):7Google Scholar
  34. 34.
    Ramel A, Arnarson A, Parra D, Kiely M, Bandarra NM, Martinéz JA, Thorsdottir I (2010) Gender difference in the prediction of weight loss by leptin among overweight adults. Ann Nutr Metab 56:190–197CrossRefGoogle Scholar
  35. 35.
    Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL (1996) Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 81:3424–3427CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Yasuyuki Nakamura
    • 1
    • 2
    Email author
  • Hirotsugu Ueshima
    • 2
  • Nagako Okuda
    • 3
  • Yoshitaka Murakami
    • 4
  • Katsuyuki Miura
    • 2
  • Yoshikuni Kita
    • 2
  • Tomonori Okamura
    • 5
  • Akira Okayama
    • 3
  • Tanvir C. Turin
    • 2
  • Sohel R. Choudhry
    • 6
  • Beatriz Rodriguez
    • 7
  • J. David Curb
    • 7
  • Jeremiah Stamler
    • 8
  1. 1.Cardiovascular EpidemiologyKyoto Women’s UniversityKyotoJapan
  2. 2.Department of Health ScienceShiga University of Medical ScienceOtsuJapan
  3. 3.The First Institute of Health Service, Japan Anti-Tuberculosis AssociationTokyoJapan
  4. 4.Department of Medical StatisticsShiga University of Medical ScienceOtsuJapan
  5. 5.Department of Preventive CardiologyNational Cardiovascular CenterSuitaJapan
  6. 6.Department of Epidemiology and ResearchNational Heart Foundation Hospital and Research InstituteDhakaBangladesh
  7. 7.Department of Geriatric Medicine, John A Burns School of MedicineUniversity of HawaiiHonoluluUSA
  8. 8.Feinberg School of MedicineNorthwestern UniversityChicagoUSA

Personalised recommendations